Arrowstreet Capital, Limited Partnership Pacira Bio Sciences, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 67,588 shares of PCRX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,588
Previous 647,318
89.56%
Holding current value
$1.57 Million
Previous $12.2 Million
86.23%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding PCRX
# of Institutions
255Shares Held
50.9MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$186 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$121 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.5 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$51.9 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$47.5 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.06B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...